Patrick Dupuy's scientific contributions
What is this page?
This page lists the scientific contributions of an author, who either does not have a ResearchGate profile, or has not yet added these contributions to their profile.
It was automatically created by ResearchGate to create a record of this author's body of work. We create such pages to advance our goal of creating and maintaining the most comprehensive scientific repository possible. In doing so, we process publicly available (personal) data relating to the author as a member of the scientific community.
If you're a ResearchGate member, you can follow this page to keep up with this author's work.
If you are this author, and you don't want us to display this page anymore, please let us know.
It was automatically created by ResearchGate to create a record of this author's body of work. We create such pages to advance our goal of creating and maintaining the most comprehensive scientific repository possible. In doing so, we process publicly available (personal) data relating to the author as a member of the scientific community.
If you're a ResearchGate member, you can follow this page to keep up with this author's work.
If you are this author, and you don't want us to display this page anymore, please let us know.
Publications (3)
A total of 334 end-stage renal disease patients with moderate-to-severe uraemic xerosis were surveyed for quality of life assessment, using the generic Short-Form (SF-12) scale and the Dermatology Life Quality Index (DLQI). In parallel, the intensity of xerosis at four sites (the two lower legs, chest, forearm without arterio-venous shunt) was asse...
To study the efficacy and safety of a new sclerosing gel of absolute ethanol in the percutaneous treatment of venous malformations (VM).
In this prospective, non-randomized multicenter study patients with clinically and by magnetic resonance imaging diagnosed VM were treated. Efficacy and safety of the gel was evaluated. Therapeutic outcome was jud...
Uremic xerosis is a bothersome condition that is poorly responsive to moisturizing and emollient therapy.
A randomized, double-blind, intraindividual (left versus right comparison), multicentric clinical study was performed on 100 patients with moderate to severe uremic xerosis for 7 days, during which the patients applied twice daily an emulsion c...
Citations
... Gelified ethanol, a composition of ethanol, is supplemented with water-insoluble cellulose derivative and embedded by a cotton wool-like network. Local adverse events, such as necrosis, temporary nerve palsy, and ethylcellulose fistulas, are reported in 12-48% of patients (25,26), therefore, this is generally similar to our findings (24%). The hospitalization period of a median of 3 days may be considered long in some countries where sclerotherapies may even be carried out as day-care procedures, which however may also reflect differences in reimbursement systems across countries. ...
![[object Object]](https://i1.rgstatic.net/ii/profile.image/273777380556802-1442285022271_Q64/Martin-Schumacher-7.jpg)
![[object Object]](https://i1.rgstatic.net/ii/profile.image/1129474984804359-1646299229983_Q64/Ulrike-Ernemann.jpg)
![[object Object]](https://i1.rgstatic.net/ii/profile.image/11431281126226441-1678622605933_Q64/Johannes-Weber.jpg)
... It is widely known that patients with CKD have a poorer quality of life than healthy patients in the general population [11,42,43]. Similarly, as we have seen in the case report of our patient, having CKD-aP affects the patient's quality of life greatly, and treating the condition is, therefore, essential [22,[44][45][46]. ...
![[object Object]](https://i1.rgstatic.net/ii/profile.image/272375887429635-1441950880327_Q64/Jacek-Szepietowski-2.jpg)
![[object Object]](https://i1.rgstatic.net/ii/profile.image/323291879804928-1454090198609_Q64/Elias-Balaskas.jpg)
... Skin hydration is a cornerstone of CKD-associated pruritus management along with other non-pharmacological strategies and should be considered for all patients with CKDassociated pruritus regardless of severity. 40,48,49 Xerosis (dry Non-pharmacological treatment strategies. Adapted from Weisshaar and colleagues 48 • Wear soft, permeable clothing; dress in layers to avoid sweating • Keep room temperature low at night • Use mild, non-alkaline, perfume-free soaps, moisturizing syndets and shower/bath oils • Apply emollients to skin twice a day, especially after bathing, and before bed • Apply cooling wet or fat-moist wraps • Limit baths to 20 minutes. ...
![[object Object]](https://i1.rgstatic.net/ii/profile.image/272460838862859-1441971134364_Q64/Dimitrios-Ioannides.jpg)
